Autophagy in Parkinson’s Disease

Lior Nechushtai, Dan Frenkel, Ronit Pinkas-Kramarski*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Parkinson’s disease (PD) is a devastating disease associated with accumulation of α-synuclein (α-Syn) within dopaminergic neurons, leading to neuronal death. PD is characterized by both motor and non-motor clinical symptoms. Several studies indicate that autophagy, an important intracellular degradation pathway, may be involved in different neurodegenerative diseases including PD. The autophagic process mediates the degradation of protein aggregates, damaged and unneeded proteins, and organelles, allowing their clearance, and thereby maintaining cell homeostasis. Impaired autophagy may cause the accumulation of abnormal proteins. Incomplete or impaired autophagy may explain the neurotoxic accumulation of protein aggregates in several neurodegenerative diseases including PD. Indeed, studies have suggested the contribution of impaired autophagy to α-Syn accumulation, the death of dopaminergic neurons, and neuroinflammation. In this review, we summarize the recent literature on the involvement of autophagy in PD pathogenesis.

Original languageEnglish
Article number1435
Issue number10
StatePublished - Oct 2023


FundersFunder number
Aufzien Center for Prevention and Treatment of Parkinson’s Disease
Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs
Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs and Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease
Association of Pediatric Program Directors
Tel Aviv University


    • Parkinson’s disease (PD)
    • apolipoprotein E4 (apoE4)
    • autophagy
    • endocytosis
    • endocytosis
    • lysosomal degradation
    • synuclein α


    Dive into the research topics of 'Autophagy in Parkinson’s Disease'. Together they form a unique fingerprint.

    Cite this